C1 - MM Galardi, C González Rührnschopf, A Sánchez Toranzo 9/2015

A

A Sánchez Toranzo// Farmacología. De la molécula al paciente. Farmacología endócrina y del metabolismo. Parte 1 Bibliografía A.N.M.A.T http://www.anmat.gov.ar/ Baek JW, Nam HK, Jin D, Oh YJ, Rhie YJ, Lee KH. 2014 Mar. Age of menarche and near adult height after long-term gonadotropin-releasing hormone agonist treatment in girls withcentral precocious puberty. Ann Pediatr Endocrinol Metab. 19(1):27-31. Buder K, Lapa C, Kreissl MC, Schirbel A, Herrmann K, Schnack A, Bröcker EB, Goebeler M, Buck AK, Becker JC. 2014 Apr. Somatostatin receptor expression in Merkel cellcarcinoma as target for molecular imaging. BMC Cancer.17(14):268. Brunton L, Chabner B, Knollman B. 2012. Goodman & Gilman. Las bases farmacológicas de la terapeútica, 12a edición, McGraw Hill Interamericana. Buendgen NK1, Schultze-Mosgau A, Cordes T, Diedrich K, Griesinger G. 2013 Oct.Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study.Arch Gynecol Obstet. 288(4):901-4. Carocci A, Catalano A, Sinicropi MS. 2014 Sep. Melatonergic drugs in development. Clin Pharmacol. 18;6:127-37. Cho KR, Jo KI, Shin HJ. 2013 Oct. Bromocriptine therapy for the treatment of invasive prolactinoma: the single institute experience. Brain Tumor Res Treat. 1(2):71-7. Cochran DM, Fallon D, Hill M, Frazier JA. 2013 Sep-Oct. “The role of oxytocin inpsychiatric disorders: a review of biological and therapeutic research findings”, Harv RevPsychiatry. 21(5):219-47. Coria-Avila GA, Manzo J, Garcia LI, Carrillo P, Miquel M, Pfaus JG. 2014 Apr 21.Neurobiology of social attachments. Neurosci Biobehav Rev.43C:173-182. Del Mastro L, Ceppi M, Poggio F, Bighin C, Peccatori F, Demeestere I, Levaggi A, GiraudiS, Lambertini M, D'Alonzo A, Canavese G, Pronzato P, Bruzzi P. 2014 Jun. Gonadotropinreleasing hormone analogues for the prevention of chemotherapy-induced prematureovarian failure in cancer women: systematic review and meta-analysis of randomized trials.Cancer Treat Rev. 40(5):675-83. Deodati A, Ferroli BB, Cianfarani S. 2014 Apr 13. Association between growth ho rmone therapy and mortality, cancer and cardiovascular risk: Systematic review and meta-analysis.Growth Horm IGF Res. pii: S1096-6374(14)20235-8. doi: 10.1016/j.ghir.2014.02.001. Diezi L, Renard D, Rothuizen LE, Livio F. 2014 Jan 15. [Pharmacovigilance update]. Rev Med Suisse. 10(412-413):119-22. Eckstein N, Haas B. 2014 Jul. Clinical pharmacology and regulatory consequences ofGnRH analogues in prostate cancer. Eur J ClinPharmacol. 70(7):791-8. Florez J, “Farmacología humana”, Elsevier Masson, 5ta edición, 2008. Frattarelli JL, Hillensjö T, Broekmans FJ, Witjes H, Elbers J, Gordon K, Mannaerts B.2013 Sep. Clinical impact of LH rises prior to and during ganirelix treatment started on day5 or on day 6 of ovarian stimulation. Reprod Biol Endocrinol. 12(11):90. Gibson CM, Penn DL, Smedley KL, Leserman J, Elliott T, Pedersen CA. 2014 Jul. A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia. Schizophr Res.156(2-3):261-5. Golier JA, Caramanica K, Makotkine I, Sher L, Yehuda R. 2014 Feb. Cortisol response to cosyntropin administration in military veterans with or without posttraumatic stressdisorder. Psychoneuroendocrinology. 40:151-8. Laudon M, Frydman-Marom A. 2014 Sep. Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders. Int J Mol Sci. 2014 Sep 9;15(9):15924-50. Huffmeijer R, Bakermans-Kranenburg MJ, Alink LR, van IJzendoorn MH. 2014 Jun. Lovewithdrawal predicts electrocortical responses to emotional faces with performancefeedback: a 62

MM Galardi, C González Rührnschopf, A Sánchez Toranzo // Farmacología del hipotálamo e hipófisis y glándula pineal follow-up and extension. BMC Neurosci. 15(1):68. Kamath C, Govindan J, Premawardhana AD, Wood SJ, Adlan MA, Premawardhana LD. 2013 Aug. Nephrogenic diabetes insipidus partially responsive to oral desmopressin in a subject with lithiuminduced multiple endocrinopathy. Clin Med.13(4):407-10. Kemp SF. 2009. Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options. BioDrugs. 23(3):155-63. Kim JH, Cho JH, Yoo HW, Choi JH. 2014 Mar. Efficacy of growth hormone therapy inadults with childhood-onset growth hormone deficiency. Ann Pediatr EndocrinolMetab.19(1):32-5. Kortenoeven ML, Sinke AP, Hadrup N, Trimpert C, Wetzels JF, Fenton RA, Deen PM.2013 Dec. Demeclocycline attenuates hyponatremia by reducing aquaporin-2 expression inthe renal inner medulla. Am J Physiol Renal Physiol.15;305(12):F1705-18. Labrie F. Combined blockade of testicular and locally made androgens in prostate cancer: A highly significant medical progress based upon intracrinology. 2014 Jun 9. J SteroidBiochem Mol Biol..pii: S0960-0760(14)00114-9. doi: 10.1016/j.jsbmb.2014.05.012. Lee YJ, Oh SH, Park C, Hong M, Lee AR, Yoo HJ, Shin CY, Cheon KA, Bahn GH. 2014 Apr. Advanced Pharmacotherapy Evidenced by Pathogenesis of Autism SpectrumDisorder. Clin Psychopharmacol Neurosci.12(1):19-30. Loche S, Carta L, Ibba A, Guzzetti C. 2014 Mar. Growth hormone treatment in non-growth hormone-deficient children. Ann Pediatr Endocrinol Metab. 19(1):1-7. Rabati BK1, Zeidi SN. 2012 Nov. Investigation of pregnancy outcome and ovarian hyper stimulation syndrome prevention in agonist and antagonist gonadotropin-releasing hormoneprotocol. J Res Med Sci.17(11):1063-6. Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G. Rang & Dale.2012.Farmacología, 7ma edición, Elsevier. Requena A, Cruz M, Ruiz FJ, García-Velasco JA. 2014 Jan 29. Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versushighly purified human menopausal gonadotropin. Reprod Biol Endocrinol.12:10. Rick FG1, Schally AV, Block NL, Abi-Chaker A, Krishan A, Szalontay L. 2013 Jun.Mechanisms of synergism between antagonists of growth hormone-releasing hormone andantagonists of luteinizing hormone-releasing hormone in shrinking experimental benignprostatic hyperplasia. Prostate. 73(8):873-83. Rich ME, deCárdenas EJ, Lee HJ, Caldwell HK. 2014 Jun. Impairments in the initiation of maternal behavior in oxytocin receptor knockout mice. PLoS One. 9 (6):e98839. doi:10.1371 / journal.pone. 0098839. eCollection 2014 Salenave S1, Boyce AM, Collins MT, Chanson P. 2014 Jun. Acromegaly and McCune-Albright Syndrome. J Clin Endocrinol Metab. 99(6):1955-69. Sánchez Toranzo A, Hansen F. 2012 Oct. Oxitocina –vasopresina: el futuro en tratamientos. Psicofarmacología. 12(76):9-14 Sharma A, Aoun P, Wigham J, Weist S, Veldhuis JD. 2013 Dec. Gender determines ACTH recovery from hypercortisolemia in healthy older humans. Metabolism. 62(12):1819-29. Shinjo E, Shiraishi K, Matsuyama H. 2013 Nov. The effect of human chorionicgonadotropin-based hormonal therapy on intratesticular testosterone levels andspermatogonial DNA synthesis in men with non-obstructive azoospermia.Andrology.1(6):929-35. Souza FM, Collett-Solberg PF. 2011 Nov. Adverse effects of growth hormone replacement therapy in children. Arq Bras Endocrinol Metabol. 55(8):559-65. Wang JW, Li Y, Mao ZG, Hu B, Jiang XB, Song BB, Wang X, Zhu YH, Wang HJ. 2014 Jan 6. Clinical EDITORIAL SCIENS 63